Article
Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival.
HLA - 1 Jan 2024
Kardol-Hoefnagel Tineke, Senejohnny Danial Mohammadi, Kamburova Elena G, Wisse Bram W, Gruijters Maartje L, Joosten Irma, Allebes Wil A, van der Meer Arnold, Hilbrands Luuk B, Baas Marije C, Spierings Eric, Hack Cornelis E, van Reekum Franka E, van Zuilen Arjan D, Verhaar Marianne C, Drop Adriaan C A D, Plaisier Loes, Melchers Rowena C A, Seelen Marc A J, Sanders Jan Stephan, Hepkema Bouke G, Kroesen Bart-Jan, Bungener Laura B, Roozendaal Caroline, Tilanus Marcel G J, Voorter Christina E, Wieten Lotte, van Duijnhoven Elly M, Gelens Mariëlle A C J, Christiaans Maarten H L, van Ittersum Frans J, Nurmohamed Shaikh A, Lardy Neubury M, Swelsen Wendy, van der Pant Karlijn A M I, van der Weerd Neelke C, Ten Berge Ineke J M, Hoitsma Andries, van der Boog Paul J M, de Fijter Johan W, Betjes Michiel G H, Roelen Dave L, Claas Frans H, Bemelman Frederike J, Heidt Sebastiaan, Otten Henny G
Abstract excerpt
In kidney transplantation, donor HLA antibodies are a risk factor for graft loss. Accessibility of donor eplets for HLA antibodies is predicted by the ElliPro score. The clinical usefulness of those scores in relation to transplant outcome is unknown. In a large Dutch kidney transplant cohort, Ellipro scores of pretransplant donor antibodies that can be assigned to known eplets (donor epitope specific HLA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.